Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia

Blood

Volumn 91, Issue 12, 1998, Pages 4451-4456

  Felix, Carolyn A ^a   Megonigal, Maureen D ^b   Chervinsky, David S ^b   Leonard, Debra G B ^b   Tsuchida, Nao ^b   Kakati, Surabhi ^b   Block, Anne Marie W ^b   Fisher, John ^b   Grossi, Mauro ^b   Salhany, Kevin I ^b   Jani Sait, Sheila N ^b   Aplan, Peter D ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; IFOSFAMIDE; PROTEIN P53; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; FLUORESCENCE IN SITU HYBRIDIZATION; GANGLIONEUROMA; GERM LINE; GRANULAR CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPE; NONSENSE MUTATION; ONCOGENE; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031838720     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N: Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood 89:596, 1997
2. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923, 1992
3. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937, 1992
4. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304, 1991
5. Kuerbitz SJ, Pkunkett BS, Walsh WV, Kastan MB: Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89:7491, 1992
6. Diller L, Sexsmith E, Gottlieb A, Li FP, Malkin D: Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest 95:1606, 1995
7. Yunis JJ: New chromosome techniques in the study of human neoplasia. Hum Pathol 12:540, 1981
8. ISCN: An International System for Human Cytogenetic Nomenclature. Cytogenet Cell Genet 40:8, 1985
9. Selleri L, Giovannini M, Hermanson GG, Romo A, Quackenbush J, Penny L, Khristich JV, Evans GA: Yeast artificial chromosome cloning of 3.2 megabases within chromosome band 11q24 closely linking c-ets 1 and fli-1 and encompassing the Ewing's sarcoma breakpoint. Genomics 22:137, 1994
10. Trask BJ, Massa H, Kenwrick S, Gitschier J: Mapping of human chromosome band Xq28 by two color fluorescence in situ hybridization analysis. Am J Hum Genet 48:1, 1991
11. McCabe NR, Burnett RC, Gill HJ, Thirman MJ, Mbangkollo D, Kipiniak M, van Meile E, Ziemin-van der Poel S, Rowley JD, Diaz MO: Cloning of cDNAs of MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 89:11794, 1992
12. Apian PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR: Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood 79:1327, 1992
13. Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang-Peng J, Knutsen T, Minna JD: Hereditary and acquired p53 mutations in childhood acute lymphoblastic leukemia. J Clin Invest 89:640, 1992
14. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoilal, Mulshine JS, Minna JD, GazdarAF: p53 gene mutations in non-small cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171, 1992
15. Hartwell L: Defects in cell cycle checkpoint may be responsible for genomic instability of cancer cells. Cell 71:543, 1992
16. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, McKenzie NJ, King G, Rabbitts TH: An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85:853, 1996
17. Felix CA, Hosier MR, Provisor D, Salhany K, Sexsmith EA, Slater DJ, Cheung N-KV, Winick NJ, Strauss EA, Heyn R, Lange BJ, Malkin D: The p53 gene in pediatric therapy-related leukemia and myelodysplasia. Blood 87:4376, 1996
18. Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE: Growth arrest induced by wild-type p53 blocks cells prior to or near the restriction point in late G1-phase. Proc Natl Acad Sci USA 89:9210, 1992
19. Mercer WE: Cell cycle regulation and the p53 tumor suppressor protein. Crit Rev Eucaryotic Gene Expression 2:251, 1992
20. Maltzman W, Czyzyk L: UV irradiation stimulates levels of p53 cellular tumor antigen in non transformed mouse cells. Mol Cell Biol 4:1689, 1984
21. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847, 1993
22. Lowe SW, Ruley HE, Jacks T, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957, 1993
23. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849, 1993
24. Lotem J, Sachs L: Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82:1092, 1993